Chen Schor - May 19, 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Nancy Smith, Attorney-in-Fact for Chen Schor
Stock symbol
KPTI
Transactions as of
May 19, 2022
Transactions value $
$0
Form type
4
Date filed
5/20/2022, 04:12 PM
Previous filing
Feb 16, 2022
Next filing
Aug 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Nonstatutory Stock Option (right to buy) Award $0 +23.9K $0.00 23.9K May 19, 2022 Common Stock 23.9K $5.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 100% of the underlying shares on the earlier of May 19, 2023 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc.